Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Arq. bras. cardiol ; 103(6,supl.2): 1-126, 12/2014. tab, graf
Artigo em Português | LILACS | ID: lil-732161
2.
Transplant Proc ; 46(6): 1842-4, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25131050

RESUMO

BACKGROUND: Heart transplantation is a treatment option for children as well as for adults with congenital heart disease. OBJECTIVE: To report the experience of a tertiary center with heart transplant program in pediatric population and in adults with congenital heart disease. PATIENTS AND METHODS: The study consisted of the evaluation of pediatric as well as adult patients undergoing heart transplantation for congenital heart disease. We evaluated the following indication and complications such as renal dialysis, graft vascular disease, tumors and survival. RESULTS: From October 1992 to November 2013, 134 patients had transplantation, and there were 139 transplantations and 5 retransplantations. The immunosuppression regimen is based on calcineurin inhibitors and cytostatic drugs. The type of heart disease indicated for transplantation was cardiomyopathies in 70% and congenital heart disease in 30%. Of these 134 patients, 85 patients were alive. Actuarial survival is 77.4%, 69.6%, 59.3% at 1, 5, and 10 years after transplantation. Three patients underwent renal transplantation, 1 patient is in renal dialysis, and 8.2% of patients had post-transplant lymphoproliferative disease. Two patients had retransplantation for graft vascular disease; 1 of them required a simultaneous kidney transplant and died 30 days after the procedure and 1 patient is clinically well 2 years after retransplantation. CONCLUSION: Heart transplantation in children and in adults with congenital heart disease is a promising therapeutic option and enables long-term survival for these patients.


Assuntos
Cardiopatias Congênitas/cirurgia , Transplante de Coração , Adolescente , Adulto , Brasil/epidemiologia , Criança , Feminino , Seguimentos , Cardiopatias Congênitas/mortalidade , Humanos , Masculino , Prognóstico , Reoperação , Estudos Retrospectivos , Taxa de Sobrevida/tendências , Adulto Jovem
3.
Arq Bras Cardiol ; 103(6 Suppl 2): 1-126, 2014 Dec.
Artigo em Português | MEDLINE | ID: mdl-25591041
5.
Arq. bras. cardiol ; 101(2,supl.3): 1-221, ago. 2013. ilus, tab
Artigo em Português | LILACS | ID: lil-685382
6.
Transplant Proc ; 44(8): 2483-5, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23026625

RESUMO

BACKGROUND: Organ transplant recipients with refractory rejection or intolerance to the prescribed immunosuppressant may respond to rescue therapy with tacrolimus. We sought to evaluate the clinical outcomes of children undergoing heart transplantation who required conversion from a cyclosporine-based, steroid-free therapy to a tacrolimus-based regimen. METHODS: We performed a prospective, observational, cohort study of 28 children who underwent conversion from cyclosporine-based, steroid-free therapy to a tacrolimus-based therapy for refractory or late rejection or intolerance to cyclosporine. RESULTS: There was complete resolution of refractory rejection episodes and adverse side effects in all patients. The incidence rate (×100) of rejection episodes before and after conversion was 7.98 and 2.11, respectively (P ≤ .0001). There was a 25% mortality rate in patients using tacrolimus after a mean period of 60 months after conversion. CONCLUSION: Tacrolimus is effective as rescue therapy for refractory rejection and is a therapeutic option for pediatric patients.


Assuntos
Ciclosporina/uso terapêutico , Rejeição de Enxerto/tratamento farmacológico , Transplante de Coração/imunologia , Imunossupressores/uso terapêutico , Tacrolimo/uso terapêutico , Fatores Etários , Criança , Pré-Escolar , Ciclosporina/efeitos adversos , Substituição de Medicamentos , Quimioterapia Combinada , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/mortalidade , Transplante de Coração/mortalidade , Humanos , Imunossupressores/efeitos adversos , Incidência , Estimativa de Kaplan-Meier , Estudos Prospectivos , Terapia de Salvação , Tacrolimo/efeitos adversos , Fatores de Tempo , Resultado do Tratamento
7.
Pediatr Cardiol ; 23(1): 20-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11924533

RESUMO

The purpose of this study was to evaluate the hemodynamic effects of inhaled nitric oxide in oxygen (NO + O2) in patients with pulmonary hypertension. Eighteen patients (median age 31.5 months) with pulmonary hypertension inhaled through a mask 100% O2 and 20 parts per million NO + inspired O2 fraction (FiO2) at 0.4. Hemodynamic measurements were made at baseline and after O2 and NO + O2 administration. The pulmonary vascular resistance index decreased after inhalation of O2 and NO + O2 (p = 0.0018 and p = 0.0003, respectively), the decrease being significantly greater after NO + O2 (p = 0.0311). Concerning the transpulmonary pressure gradient, a reduction occurred in values after O2 and NO + O2 inhalation when compared with baseline values (p = 0.0014 and p = 0.0008). In patients with congenital heart disease, an increase occurred in pulmonary blood flow after O2 (p = 0.0089) and NO + O2 (p = 0.0019) compared with baseline values, and an increase also occurred in the pulmonary/systemic blood flow ratio after NO + O2 (p = 0.0017). The main side effect related to NO + O2 was pulmonary congestion in 3 patients. Low doses of NO combined with O2 demonstrated a selective pulmonary vasodilator response in patients with pulmonary hypertension. Despite its use for testing pulmonary reactivity, inhalation of NO + O2 should be carefully administered because of the potential risk of pulmonary congestion.


Assuntos
Cardiopatias Congênitas/fisiopatologia , Hipertensão Pulmonar/tratamento farmacológico , Óxido Nítrico/uso terapêutico , Vasodilatadores/uso terapêutico , Administração por Inalação , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Hipertensão Pulmonar/fisiopatologia , Lactente , Masculino , Óxido Nítrico/administração & dosagem , Vasodilatadores/administração & dosagem
8.
Arq Bras Cardiol ; 77(1): 69-76, 2001 Jul.
Artigo em Inglês, Português | MEDLINE | ID: mdl-11500750

RESUMO

We report the case of an 8-month-old female infant with Uhl's anomaly, who underwent successful cardiac transplantation. The clinical findings, complementary laboratory tests, anatomic findings, and differential diagnosis of the anomaly are discussed.


Assuntos
Cardiopatias Congênitas/diagnóstico , Transplante de Coração/métodos , Ventrículos do Coração/anormalidades , Diagnóstico Diferencial , Feminino , Cardiopatias Congênitas/patologia , Cardiopatias Congênitas/cirurgia , Humanos , Lactente
10.
Arq Bras Cardiol ; 74(3): 197-208, 2000 Mar.
Artigo em Inglês, Português | MEDLINE | ID: mdl-10951823

RESUMO

OBJECTIVE: To assess intermediate-term outcome in children who have undergone orthotopic heart transplantation. METHODS: We carried out a longitudinal and prospective study between October '92 and June '99 comprising 20 patients with ages ranging from 12 days to 7 years (mean of 2.8 years). We employed a double immunosuppression protocol with cyclosporine and azathioprine and induction therapy with polyclonal antithymocyte serum. Survival and complications resulting from the immunosuppression protocol were analyzed. RESULTS: The double immunosuppression protocol and the induction therapy with polyclonal antithymocyte serum resulted in an actuarial survival curve of 90% and 78.2% at 1 and 6 years, respectively, with a mean follow-up period of 3.6 years. One patient died due to acute rejection 40 days after transplantation; another patient died 2 years after transplantation due to lymphoproliferative disorder; a third patient died because of primary failure of the graft; and a fourth patient died due to bronchopneumonia. The major complications were as follows: acute rejection, infection, nephrotoxicity, and systemic hypertension. The means of rejection and infection episodes per patient were 2.9 and 3.4, respectively. After one year of transplantation, a slight reduction in the creatinine clearance and systemic hypertension were observed in 7 (38.9%) patients. CONCLUSION: Heart transplantation made life possible for those patients with complex congenital heart diseases and cardiomyopathies in refractory congestive heart failure constituting a therapeutical option for this group of patients in the terminal phase.


Assuntos
Transplante de Coração/mortalidade , Cardiomiopatias/cirurgia , Criança , Pré-Escolar , Feminino , Seguimentos , Rejeição de Enxerto/diagnóstico , Cardiopatias Congênitas/cirurgia , Insuficiência Cardíaca/cirurgia , Transplante de Coração/efeitos adversos , Humanos , Terapia de Imunossupressão/efeitos adversos , Terapia de Imunossupressão/métodos , Lactente , Recém-Nascido , Estudos Longitudinais , Masculino , Estudos Prospectivos , Análise de Sobrevida
12.
Arq Bras Cardiol ; 73(2): 219-24, 1999 Aug.
Artigo em Inglês, Português | MEDLINE | ID: mdl-10752191

RESUMO

Ebstein's anomaly with coarctation of the aorta is an extremely unusual condition. In this report, the clinical and surgical features of 3 male patients, aged 7 months, 4 years and 14 years, are discussed. All patients were in situs solitus. The first 2 patients had atrioventricular and ventriculoarterial discordance and progressed to heart failure in the neonatal period. The third had atrioventricular and ventriculoarterial concordance, as well as Wolf-Parkinson-White syndrome, with frequent episodes of paroxysmal tachycardia. The 3 patients underwent surgery for correction of the coarctation of the aorta. The patient with atrioventricular and ventriculoarterial concordance underwent tricuspid valvuloplasty using a DeVega-like technique. In addition, ablation of 2 anomalous pathways (Kent bundle), which were detected by the electrophysiologic study, was also subsequently performed. The 3 patients showed a good postoperative outcome for 2 years, although, in those with discordance, the surgical procedure did not influence the dysplasia of the tricuspid valve, because this valve showed light to moderate dysfunction.


Assuntos
Coartação Aórtica/complicações , Anomalia de Ebstein/complicações , Adolescente , Coartação Aórtica/diagnóstico , Coartação Aórtica/cirurgia , Pré-Escolar , Anomalia de Ebstein/diagnóstico , Eletrocardiografia , Doenças das Valvas Cardíacas/diagnóstico , Doenças das Valvas Cardíacas/cirurgia , Humanos , Lactente , Masculino , Valva Tricúspide/cirurgia
13.
Pediatr Neurol ; 19(2): 113-8, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9744630

RESUMO

Eleven children, 4-48 months old, with congenital cyanotic heart defects developed choreoathetoid movements 2-12 days after cardiac surgery with hypothermia and extracorporeal circulation (ECC). The abnormal movements mainly involved the limbs, facial musculature, and tongue, leading to a severe dysphagia. The symptoms had an acute onset, after a period of apparent neurologic normality, and had a variable outcome. Of the nine children that survive, three had abnormal movements when last seen (41 days to 12 months of follow-up). The other six children had a complete regression of the choreoathetoid movements 1-4 weeks after onset. No specific finding was observed in the CT scans, cerebrospinal fluid examination, or EEG that could be related to the abnormal movements. Symptomatic therapy with haloperidol with or without benzodiazepines led to symptomatic improvement in six children, although there was no evidence that this treatment modified the evolution of the disease. The authors conclude that the choreoathetoid syndrome after cardiac surgery with deep hypothermia and ECC is an ill-defined entity requiring additional study to better understand its pathogenesis so that preventive measures can be taken to avoid a condition that can lead to permanent and incapacitating neurologic sequelae.


Assuntos
Atetose/etiologia , Procedimentos Cirúrgicos Cardíacos , Coreia/etiologia , Circulação Extracorpórea , Hipotermia Induzida , Complicações Pós-Operatórias , Adolescente , Antidiscinéticos/uso terapêutico , Atetose/tratamento farmacológico , Benzodiazepinas/uso terapêutico , Coreia/tratamento farmacológico , Eletroencefalografia , Feminino , Haloperidol/uso terapêutico , Humanos , Lactente , Masculino , Cuidados Pós-Operatórios , Complicações Pós-Operatórias/mortalidade , Período Pós-Operatório
14.
Arq Bras Cardiol ; 71(5): 661-6, 1998 Nov.
Artigo em Português | MEDLINE | ID: mdl-10347948

RESUMO

PURPOSE: To evaluate hemodynamic parameters and clinical outcome of children with severe cardiomyopathy who are candidates for heart transplantation. METHODS: Twenty four children aged from 4 months to 10 years and 8 months (mean 3.7 +/- 2.5 years) from February 1992 to May 1996, were submitted to hemodynamic study and the following parameters were measured: cardiac output, mean pulmonary artery pressure (MPAP) and capillary wedge pressure. The pulmonary vascular resistance index (PVRI) and transpulmonary pressure gradient (TGP) were calculated. RESULTS: Ten (41.6%) children were transplanted (group A), 5 (20.8%) are still waiting heart transplantation (group B) and 9 (37.6%) died (group C). The mean age of the B and C group were significantly different. The PVRI, MPAP and TPG were significant lower in group A than group C (p = 0.01; p = 0.044 and p = 0.023 respectively). CONCLUSION: The profile of the hemodynamic parameters of children with severe dilated cardiomyopathy was compatible with the clinical findings. The age was the only difference comparing groups B and C. PVRI, MPAP and TPG were significant factors between group A and C. The older the patient, the worse was the prognosis.


Assuntos
Cardiomiopatia Dilatada/cirurgia , Transplante de Coração , Fatores Etários , Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/fisiopatologia , Criança , Pré-Escolar , Transplante de Coração/fisiologia , Hemodinâmica/fisiologia , Humanos , Lactente
15.
Arq Bras Cardiol ; 68(1): 3-8, 1997 Jan.
Artigo em Português | MEDLINE | ID: mdl-9334452

RESUMO

PURPOSE: To determine the value of the quantitative analysis of lung biopsies from patients with congenital cardiac defects. METHODS: Fourty nine biopsies were examined, from patients: 43 patients increased pulmonary blood flow, 3 with pulmonary atresia and large systemic-to-pulmonary collateral vessels, and 3 with decreased pulmonary flow. The degree of lesion was determined as in Heath-Edwards and of Rabinovitch and col. RESULTS: The Heath and Edwards grade was determined in 41 cases; I in nine; II in 23; III in eight; IV in one; 3 biopsies showed evidence of reduced pulmonary flow and 5 had no signs of vascular disease. The Down patients (7) presented a greater proportion of severe lesions. Quantitative evaluation was obtained in 35 biopsies: 11 had grade B and 24 had grade C. Wall atrophy and dilatation of intraacinar arteries were detected in 7 cases, what suggested the existence of obstructive lesions in proximal vessels, even if not sampled. Medical thickness greater than 2 times the normal were observed in pre-acinar arteries from 14 biopsies. CONCLUSION: The morphometric approach allowed us to detect severe lesions which the qualitative analysis alone would not indicate adequately. In the patients presenting decreased pulmonary flow, morphometry made possible to assess if the degree of arterial wall hypertrophy was compatible with a surgery of atrio-pulmonary anastomosis.


Assuntos
Cardiopatias Congênitas/complicações , Hipertensão Pulmonar/etiologia , Pulmão/patologia , Artéria Pulmonar/patologia , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Hipertensão Pulmonar/patologia , Lactente , Masculino , Estudos Retrospectivos , Índice de Gravidade de Doença
16.
Arq Bras Cardiol ; 67(3): 165-70, 1996 Sep.
Artigo em Português | MEDLINE | ID: mdl-9181709

RESUMO

PURPOSE: Heart transplantation has offered children with complex congenital heart diseases and severe cardiomyopathies a chance for survival. The present article was written to show the three year experience of this procedure at the Instituto do Coração-HCFMUSP. METHODS: The methodology used was based on heart transplant indication criteria, inclusion criteria for donors, postoperative management, immunosuppression and prophylaxis as well as treatment of potential complications. RESULTS: From November 1992 to November 1995, 11 children, aged 12 days old to six years (mean 2.5 years) underwent transplantation. Sixty percent of recipients were male; weight ranged from 3.5 to 17.8 kg (mean 10.3 kg). The mean age of donors was 4.4 years (a range of three weeks to ten years), 80% male, weight ranging from 3.8 to 20 kg (median 14.3 kg). The survival rate was 91% and the remaining 10 children are doing well. The most important complications were systemic hypertension, acute rejection and infection. The number of rejections and infections per patient were 3.5 and 4.7 episodes, respectively. The follow-up was between one month to three years (average 16 months). CONCLUSION: In this experience, heart transplantation has given an additional opportunity for children with complex congenital heart diseases and cardiomyopathies, with a survival rate of 91% in three years.


Assuntos
Transplante de Coração , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Lactente , Recém-Nascido , Masculino , Complicações Pós-Operatórias , Período Pós-Operatório
17.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 5(6): 695-701, nov.-dez. 1995. ilus
Artigo em Português | LILACS | ID: lil-165767

RESUMO

O transplante cardíaco tem proporcionado às crianças portadoras de cardiopatias congênitas complexas e cardiomiopatias refratárias a oportunidade terapêutica de sobrevivência e melhorar da qualidade de vida. Controlando-se as possíveis variáveis perioperatórias, pode-se chegar a sobrevivência de 95 por cento no primeiro ano de vida e de 75 por cento em cinco anos. É importante salientar que säo determinantes, para a boa evoluçäo do transplante, o conhecimento de alguns aspectos, como critérios de ilusäo e manuseio pré-operatório de receptores, seleçäo de potenciais doadores, manuseio pós-operatório, imunossupressäo, bem como prevençäo e tratamento de potenciais complicaçöes.


Assuntos
Criança , Rejeição de Enxerto , Transplante de Coração , Terapia de Imunossupressão , Infecções , Qualidade de Vida
18.
Arq Bras Cardiol ; 60(1): 39-42, 1993 Jan.
Artigo em Português | MEDLINE | ID: mdl-8240041

RESUMO

Ischemic cardiomyopathy in childhood is related with congenital and acquired pathologies which could lead to serious cardiac sequelae as myocardial infarction and sudden death. Unfortunately, when coronary artery malformations are excluded, it is difficult in some cases to be completely certain on the etiology of the arterial coronary disease, due the lack of pathognomonic diagnostic tests. Case report of 6 year old child, with severe coronary artery disease: aneurysm of main branch of left coronary artery; left anterior descending branch and right coronary artery occlusions with accentuated myocardial dysfunction. We believe that the diagnosis of Kawasaki disease is presumptive in this patient. The principal aspects to elucidate the etiology of coronary artery disease are analysed, as well as the importance of identifying patients without known previous illness, but with severe coronary artery lesions, as in this reported case.


Assuntos
Aneurisma Coronário/diagnóstico , Isquemia Miocárdica/diagnóstico , Criança , Aneurisma Coronário/complicações , Humanos , Masculino , Síndrome de Linfonodos Mucocutâneos/complicações , Síndrome de Linfonodos Mucocutâneos/diagnóstico , Isquemia Miocárdica/etiologia
19.
Arq Bras Cardiol ; 58(2): 121-3, 1992 Feb.
Artigo em Português | MEDLINE | ID: mdl-1307457

RESUMO

Three newborn children with cyanosis due to Ebstein's anomaly of tricuspid valve with an important hemodynamic repercussion presented features of imperforation of pulmonary valve. On the follow-up, clinical and laboratory findings verified that pulmonary atresia was functional resulting from a combination of low right ventricular pressure and high pulmonary vascular resistance.


Assuntos
Valva Pulmonar/anormalidades , Anomalia de Ebstein/complicações , Ecocardiografia Doppler , Eletrocardiografia , Humanos , Recém-Nascido , Prostaglandinas E/uso terapêutico , Vetorcardiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA